Revenue and Network Growth Continues in Q3 2025TORONTO, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Clip Money Inc. (TSX-V: CLIP) (“Clip Money” or the “Company”), a company that operates a multi-bank self-service deposit system for businesses, is pleased to announce its financial results for the three and nine months ended September 30, 2025. The Company reported continued revenue growth in the third quarter of 2025, up 175% from Q3 2024, while cost of revenues were up only 55% during the same time period, maintainin ...

Provider of Smart City and Building Solutions Joins Itron Engage Channel Partner ProgramLIBERTY LAKE, Wash., Nov. 19, 2025 (GLOBE NEWSWIRE) -- Itron, Inc. (NASDAQ: ITRI), which is innovating new ways for utilities and cities to manage energy and water, announced that Connected Lighting Solutions (CLS) has joined the Itron Engage Sales Channel Partner Program in Australia. CLS, a subsidiary of the Beacon Lighting Group and a leading provider in intelligent street lighting systems, will support the deployment ...

Core Points - Galway Metals Inc. has entered into an agreement with Red Cloud Securities Inc. for a private placement aiming to raise up to C$10,000,000.55 through the sale of units and flow-through units [1][4] - The offering includes 3,703,704 units priced at C$0.54 each and 10,596,027 flow-through units priced at C$0.755 each [1][2] - The proceeds will be used for exploration of the Clarence Stream gold project and for general corporate purposes [4][5] Offering Details - Each unit consists of one common share and one-half of a common share purchase warrant, while each flow-through unit consists of one flow-through share and one-half of a warrant [2] - The warrants allow the holder to purchase one common share at C$0.80 within 36 months after the closing date [2] - An option is granted to Red Cloud to sell an additional C$1,500,000 in units and flow-through units prior to the closing [3] Regulatory and Closing Information - The offering is subject to regulatory approvals and is scheduled to close on December 10, 2025 [8] - The securities will be offered to purchasers in several Canadian provinces and may also be sold in offshore jurisdictions [6] Company Overview - Galway Metals is focused on advancing its 100%-owned Clarence Stream gold project in New Brunswick, which has a significant exploration potential [11] - The company also owns the Estrades project, a former high-grade polymetallic mine in Quebec [11] - The management team has a proven track record of creating shareholder value, having previously sold Galway Resources for US$340 million [11]

Core Insights - Profusa, Inc. has successfully reduced its net debt from $34 million to $14 million as of October 31, 2025, following a merger with NorthView Acquisition Corporation [2][9] - The company aims to achieve potential revenues of $200 to $250 million by 2030, with near-term revenue targets of $0.5 to $2 million for 2026 and $9 to $13 million for 2027 [4] Business Highlights - The merger with NorthView Acquisition Corporation was completed, resulting in a company equity value of $155 million [8] - Manufacturing capabilities have been built out, with plans to begin product shipments and generate revenue in early 2026 [8] - Profusa has expanded its sales footprint in Europe, currently covering approximately 35% of the European population for its Lumee™ Oxygen tissue monitoring platform [8] - The company has entered into several clinical and commercial collaborations with prominent vascular surgeons [8] Financial Highlights - Profusa raised $12 million in gross proceeds from a convertible PIPE note, with $10 million remaining available [9] - An additional $7 million was raised through an Equity Line of Credit (ELOC) as of October 31, 2025, with $93 million still available [9] - Cash and cash equivalents increased to $4 million, and net debt was reduced to $14 million as of October 31, 2025, down from $48 million last quarter [9]

Core Insights - Apollomics Inc. has entered into a settlement agreement with TWVC Goldlink Partners Investment Limited and TWVC Panglin Group Investment Limited to resolve litigation related to preferred share redemption claims before its merger with Maxpro Capital Acquisition Corporation in 2023 [1][2] Financial Summary - The settlement agreement requires Apollomics to pay a total of US$5 million in cash to TWVC, to be paid in installments over two years, along with approximately US$879,757.78 in legal expenses [2] - The original damages claimed by TWVC were approximately US$40 million, as disclosed in the Form 20-F filed in April 2025 [2] Company Overview - Apollomics Inc. is a clinical-stage biopharmaceutical company focused on developing oncology therapies that can be combined with other treatments to target specific molecular pathways and harness the immune system [3] - The company's lead program is vebreltinib (APL-101), a selective c-Met inhibitor for treating non-small cell lung cancer and other advanced tumors with c-Met alterations, currently in a Phase 2 multicohort clinical trial [3]

Core Viewpoint - Automotive Finco Corp. has filed its condensed interim consolidated financial statements for the nine months ended September 30, 2025, and is exploring strategic alternatives to return cash to shareholders efficiently [1][2]. Financial Performance - The total amount received from the Partnership's loan investment, including all outstanding interest, was $26,608,540 [2]. Company Overview - Automotive Finco Corp. is a finance company focused exclusively on the auto retail sector and may pursue other direct investments and financing opportunities within this sector [3].

Core Insights - Extendicare Inc. announced the acquisition of CBI Home Health for a cash purchase price of $570 million, which will enhance its service offerings and strengthen its market position in home health care [2][3][11] - The acquisition is expected to generate significant synergies and improve financial metrics, including a projected 20% accretion in AFFO per share and 15% in earnings per share [9][11] Acquisition Details - The acquisition will be funded through a combination of a $264.5 million upsizing to Extendicare's existing credit facility and a $200 million bought deal private placement equity offering [5][15][16] - CBI Home Health delivered over 10 million hours of care annually across seven provinces, with a revenue of approximately $477.9 million and an Adjusted EBITDA of $61.9 million for the twelve months ended July 31, 2025 [10][11] Financial Metrics - The acquisition price represents an estimated purchase price multiple of 9.4x CBI Home Health's Adjusted EBITDA, which could improve to approximately 8.4x after accounting for expected synergies of about $7.4 million [11][12] - Extendicare's pro forma total debt to Adjusted EBITDA ratio is projected to be 3.3x as of September 30, 2025, post-acquisition [8][15] Strategic Rationale - The acquisition aligns with Extendicare's growth strategy by enhancing its capabilities in home health care and expanding its geographic footprint, particularly in Western Canada [6][9] - The combination of ParaMed and CBI Home Health is expected to improve access to community-based care and leverage technology for better customer experience and cost efficiencies [6][9] Offering Details - Extendicare plans to issue 10.64 million common shares at a price of $18.80 per share, aiming for gross proceeds of approximately $200 million from the private placement [5][17] - The closing of the offering is anticipated around December 3, 2025, subject to regulatory approvals [17]

Core Points - TILT Holdings Inc. announced that the Supreme Court of British Columbia granted an order for a meeting of noteholders to vote on a proposed Plan of Arrangement on December 1, 2025 [1] - If the Plan is approved by the required majority, TILT intends to seek court sanctioning of the Plan on December 5, 2025 [1] Company Overview - TILT Holdings Inc. is a global provider of cannabis business solutions, including inhalation technologies, cultivation, manufacturing, processing, brand development, and retail [2] - The company operates a diverse portfolio, including Jupiter Research LLC, which focuses on vaporization technology and recently received EU medical device certification for a handheld liquid inhalation device [2] - TILT also operates Commonwealth Alternative Care, Inc. in Massachusetts and Standard Farms Ohio, LLC in Ohio, and holds a permit for Standard Farms LLC in Pennsylvania [2] Future Plans - The company is focused on restructuring and optimizing its business strategy, including potential reductions in corporate overhead and headcount [3][4] - TILT aims to strengthen its balance sheet and enhance shareholder value through its ongoing business optimization strategy [3][4]

Core Viewpoint - DAVIDsTEA Inc. has successfully closed a private placement of units amounting to $3 million, aimed at expanding its store presence in Canada and supporting working capital needs [1][2]. Group 1: Private Placement Details - The private placement involved the issuance of 3,333,334 units at a price of $0.90 per unit, generating total proceeds of $3 million [2]. - Each unit consists of one common share and one-half of a common share purchase warrant, with full warrants allowing the purchase of additional shares at $1.25 for one year and $1.50 for the subsequent year [2]. - The warrants may expire if the closing price of DAVIDsTEA's shares reaches at least $2.00 for 20 consecutive trading days, with a notice period of 30 days for warrant holders [2]. Group 2: Company Overview - DAVIDsTEA is a leading North American tea merchant, offering a variety of high-quality proprietary loose-leaf teas, pre-packaged teas, and tea-related accessories through its e-commerce platform and wholesale channels [5]. - The company serves over 4,000 grocery stores and pharmacies, 1,500 convenience stores in Canada, and 900 grocery stores in the United States, alongside operating 20 company-owned stores in Canada [5]. - DAVIDsTEA focuses on innovative flavors and wellness-driven ingredients, launching seasonal collections to make tea enjoyable and accessible [5].

Continued Focus on Operational Execution and Strategic TransformationSKOKIE, Ill., Nov. 19, 2025 (GLOBE NEWSWIRE) -- LanzaTech Global, Inc. (NASDAQ: LNZA) (“LanzaTech” or the “Company”), a carbon management solutions company, today reported its financial and operating results for the third quarter ended September 30, 2025. Key Highlights: First Commercial Ethanol-to-Jet Plant Operational: In November 2025, LanzaJet, Inc., a sustainable aviation fuel ("SAF") joint venture entity in which the Company has a 36 ...